Introduction {#sec1}
============

Deep venous thrombosis (DVT) is a known complication of total joint replacement surgery and, without appropriate anticoagulation prophylaxis, the prevalence of DVT is reported to be 40--80% in total knee replacements, 50--60% in total hip replacements, and 30--60% after hip fracture [@bib1], [@bib2]. The associated risk of pulmonary embolism is approximately 10% with an overall fatality rate of 5% [@bib1], [@bib2]. Several anticoagulation prophylaxis modalities, including pharmacological and mechanical methods, have been designed to prevent this complication. However, pharmacological agents, such as unfractionated heparin, warfarin, low-molecular-weight-heparin, or rivaroxaban, are not without risks [@bib3]. Development of hematoma, persistent hemorrhage, and wound complications are among the commonly reported pharmacophylaxis-related complications [@bib3], [@bib4].

Acute bilateral adrenal hemorrhage (BAH), although rare, has been reported as a potentially catastrophic complication of anticoagulation therapy [@bib1], [@bib5], [@bib6], [@bib7]. However, this condition also occurs in the settings of post-operative period, septicemia, pregnancy, anti-phospholipid syndrome, heparin-associated thrombocytopenia, trauma, and coagulopathies [@bib1], [@bib5], [@bib6], [@bib7].

BAH presents a diagnostic challenge to treating physicians due to non-specific complaints and symptoms that range from vague abdominal pain, nausea, vomiting, neuropsychiatric symptoms, hypotension or shock, and fever [@bib5], [@bib6], [@bib7].

To our knowledge, several case reports of BAH from warfarin and unfractionated heparin exist in a subset of orthopedic patients undergoing joint replacement surgeries [@bib1], [@bib5], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20]. However, this is the first reported case of enoxaparin-induced BAH following arthroplasty. We report a case of BAH secondary to enoxaparin use after unilateral knee replacement surgery.

Case history {#sec2}
============

A 65 year-old female with end-stage osteoarthritis of the right knee had progressively worsening joint pain that was refractory to all non-operative measures. The patient\'s medical comorbidities included well-controlled hypertension, gastroesophageal reflux disease, and remote history of DVT. Once the patient failed non-operative management of her osteoarthritis, the patient was recommended to undergo right total knee arthroplasty. The risks and the benefits of the surgery were explained, and informed consent was obtained. The patient\'s perioperative and post-operative courses were uncomplicated, and was discharged home on post-operative day (POD) two. The patient was placed on enoxaparin (30 mg B.I.D) for DVT prophylaxis on POD one and was discharged home with the same regimen for an additional ten days.

On POD eight, the patient was admitted with complaints of vague epigastric pain, lethargy, and febrile episodes. Symptoms included decreased appetite, somnolence, anxiety, and nausea without vomiting. Physical examination was unremarkable, and vital signs included temperature 101.7 F, heart rate 111, respiration 20, blood pressure 123/87, and oxygen saturation 92% at admission. Laboratory values showed significant hyponatremia (126), hypokalemia (2.6), glucose (60), hematocrit (25.3), creatinine (0.8), WBC count (14,900), and platelet count (161,000). The patient was immediately evaluated, and the differential diagnosis included pulmonary embolism, sepsis, metabolic encephalopathy, and adrenal insufficiency.

However, the patient\'s chest CT scan was negative for pulmonary embolism, and the MRI of the brain was negative for acute pathology. The medicine team was concerned for presumed sepsis, and empirical intravenous antibiotics (ceftriaxone, vancomycin, and acyclovir) were promptly started, and various cultures including CSF, urine, and blood were obtained.

The patient deteriorated rapidly and was transferred to the intensive care unit and received aggressive intravenous volume support with pressors. Subsequent clinical and laboratory findings suggested possible adrenal insufficiency. Basal cortisol levels were obtained before and after cosyntropin (ACTH) stimulation, and both values were 0.3 nmol/L. Abdominal CT revealed bilateral adrenal hemorrhages ([Fig. 1](#fig1){ref-type="fig"}). Enoxaparin was immediately discontinued, and the patient was started on high dose hydrocortisone. The patient improved dramatically and subsequently left the intensive care unit within 24--48 h of glucocorticoid administration. Glucocorticoid was tapered, and the patient improved clinically and was discharged without further complications.

The patient most recently followed up with the senior author at her 1-year visit, and her knee has excellent range of motion, and X-rays demonstrate well-placed components with no evidence of loosening. She has since returned to her previous activity level including bowling.

Discussion {#sec3}
==========

Multiple guidelines exist in order to assist physicians with clinical decisions regarding DVT prophylaxis for elective joint replacement surgery patients [@bib3], [@bib11]. While both mechanical and pharmacological methods are effective, chemoprophylaxis remains a popular choice due to its higher compliance rate and ease of use [@bib3], [@bib11]. However, chemoprophylaxis is associated with increased risk of bleeding, wound complications, and heparin-induced thrombocytopenia [@bib3], [@bib4], [@bib6], [@bib11], [@bib17]. BAH is a rare complication of chemoprophylaxis. While spontaneous adrenal hemorrhage has been reported, BAH has been reported in settings of sepsis, trauma, intra-operative/post-operative complications, severe burns, anticoagulant therapy, other coagulopathies [@bib6], [@bib7], [@bib17].

Following a detailed literature search for BAH cases in hip and knee arthroplasty patients, a total of 16 cases were identified ([Table 1](#tbl1){ref-type="table"}). The mean age was 66.5. Six patients (37.5%) underwent bilateral total knee replacements, and one patient underwent revision total knee arthroplasty. Clinical symptoms and signs are summarized in [Table 2](#tbl2){ref-type="table"}. Some patients presented with laboratory abnormalities, such as, hyponatremia (8 patients) and hypokalemia (2). Acute anemia was present in two patients, and thrombocytopenia was present in seven patients. BAH was determined at the time of autopsy in two cases.

In seven cases, heparin-induced-thrombocytopenia was identified as the cause of BAH after confirmatory HIT antibody tests, however, in three cases (including our case), the HIT antibody test was negative. In our patient, platelet count was 161,000 at initial presentation, and remained between 200,000 and 250,000 during hospitalization. Abdominal CT scans revealed BAH in 12 of 16 patients, and it was the most reliable diagnostic test. In 10 of 16 patients, acute adrenal insufficiency was further confirmed by a cosyntropin stimulation test, and these patients received corticosteroids and made remarkable recovery within 24--48 h.

BAH often presents with non-specific signs and symptoms, and clinical associations are commonly unrecognized, making prospective diagnosis and early treatment exceedingly difficult. Physical examinations are rarely diagnostic, with fever and abdominal pain being two consistent clinical features [@bib5], [@bib18], [@bib19]. Laboratory clues include unexplained drop in hematocrit, leukocytosis, eosinophilia, hyponatremia, hyperkalemia, and hypoglycemia [@bib1], [@bib5], [@bib6], [@bib7], [@bib8], [@bib11], [@bib12], [@bib19], [@bib20], [@bib23]. While the biochemical evidence of adrenal insufficiency including hyponatremia and hyperkalemia with volume contraction can provide diagnostic clues for acute adrenal insufficiency, not all patients presented with such laboratory abnormalities. Only 8 of 16 patients presented with hyponatremia, two patients had hypokalemia only, and no patient had hyperkalemia at the time of presentation.

CT, MRI and U/S are recommended diagnostic BAH imaging modalities [@bib19]. Diagnosis is made on abdominal CT or MRI with common characteristics featuring bilateral rounded adrenal gland enlargement, confirmed by cosyntropin stimulation. The mass seen on CT and MRI of adrenal gland with no enhancement or enhancement only in a pattern of a thin peripheral rim can be used to distinguish hematoma from other pathologies [@bib12], [@bib21].

When suspicious for acute adrenal insufficiency, cosyntropin stimulation should be performed to measure the adrenal gland response to a cosyntropin challenge at 30 and 60 min intervals. A normal, appropriate response is approximately a two-fold increase in serum cortisol levels after cosyntropin administration [@bib5], [@bib6], [@bib18]. With steroid administration, the dramatic improvement in the cardiovascular status was usually seen, and all patients who received the corticosteroid therapy made remarkable recovery within 24--48 h of administration [@bib7], [@bib18], [@bib22]. However, the clinical course of this disease does not always follow a favorable one, and, once the shock is too severe, even large doses of steroids may be ineffective [@bib18].

The loss of adrenal function associated with adrenal atrophy is almost universal in patients who survived acute adrenal insufficiency [@bib22]. While our patient did not require long-term steroid therapy, all 10 patients in the literature who recovered via the corticosteroid replacement therapy were placed on long-term replacement therapy.

Rao et al. reported their experience in treating several patients with BAH and developed an algorithm for the diagnosis and treatment of bilateral massive adrenal hemorrhage [@bib18]. In this algorithm, they have categorized the progression of the disease into different levels depending on the severity of cardiopulmonary status [@bib18]. They emphasized the importance of having high clinical suspicion for BAH and recommended early intervention with intravenous corticosteroids.

Summary {#sec4}
=======

BAH is a rare complication that can occur with DVT prophylaxis such as enoxaparin or coumadin. Total joint patients with chemoprophylaxis, who present with non-specific symptoms including abdominal distress, fever, and anxiety related complaints on post-operative day 4--10, should not be ignored, and a high index of clinical suspicion is required to prevent this catastrophic event. CT scans and hormone assays should be obtained at earliest suspicion of acute adrenal insufficiency, and presumptive steroid treatment should be initiated while awaiting confirmatory tests.
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###### 

Characteristics of total arthroplasty patients who suffered bilateral adrenal hemorrhages (BAH).

  Author                         Age   Sex   Procedure   Post op days   Dvt prophylaxis           Outcome   Complaints                                                                     Initial labs                   Imaging   HIT   Tx
  ------------------------------ ----- ----- ----------- -------------- ------------------------- --------- ------------------------------------------------------------------------------ ------------------------------ --------- ----- ------------------------------------------
  Laban et al. [@bib1]           83    F     B/L TKA     8              SQ heparin and warfarin   DC home   Epigastric pain, nausea                                                        Na 126, K 3.4, no anemia       CT        Unk   Hydrocortisone
  Rajamanickam et al. [@bib5]    52    M     B/L TKA     9              Enoxaparin                dc home   Abdominal pain, nausea, vomiting, constipation, shock, confusion, fever        Na 134, hct 30, HIT neg        CT        No    Hydorcortisone
  Barrou et al. [@bib8]          80    M     TKA         6              Enoxaparin                DC home   Abdominal pain, anxiety, confusion, fever, hypotension                         Na 129, K 5.5                  CT        No    Corticosteroids
  Best et al. [@bib9]            75    F     THA         9              Dabigatran                Unknown   Sob, fever, ab pain                                                            Unknown                        CT        Unk   Unknown
  Bleasel et al. [@bib10]        69    F     TKA rev     Unknown        SQ heparin                Unknown   Fever, nausea, vomiting, abdominal pain                                        Unknown                        None      Yes   Unknown
  Chow et al. [@bib11]           44    M     B/L TKA     10             Heparin drip              DC home   Abdominal pain, tachycardia, fever                                             Na 124, K 4.9, low platelets   CT        Yes   Methylprednisolone, hydrocortisone taper
  Cozzolino et al. [@bib12]      66    F     TKA         7              Coumadin                  DC home   Nausea, anorexia, and emesis                                                   Na 129, K 5.2, Hct 23          CT        Unk   Corticosteroids
  Delhumeau et al. [@bib13]      74    M     THA         4              SQ heparin                Unknown   Abdominal pain, fever, hypotention, ab tenderness                              Unknown                        CT        Yes   Unknown
  Ernest et al. [@bib14]         68    F     THA         Unknown        SQ heparin                Unknown   Shock                                                                                                                   Yes   
  Hardwicke et al. [@bib15]      63    F     B/L TKA     7              SQ heparin and warfarin   DC home   Nausea, vomiting, anorexia, vague feeling of illness, hypotension, dizziness   Na 127, K 4.6                  CT        Unk   Dexamthasone
  Kurtz et al. [@bib16]          54    F     THA         Unknown        SQ dalteparin             Alive     Fever, abdominal pain, anorexia                                                Na 131, NL K, low PLT          CT        Yes   Corticosteroids
  Mongardon et al. [@bib17]      64    M     THA         7              SQ heparin                Alive     Fever, abdominal pain, shock                                                   Normal labs                    CT        Yes   Corticosteroids
  Schuchmann et al. [@bib19]     83    F     B/L TKA     5              SQ heparin                Death     Anxious, sob, shock, fever                                                     Na 122, K 4.2, Hct 31.2        None      Unk   None
  Souied et al. [@bib20]         63    F     THA         10             SQ heparin                Death     Hypotension, shock, fever                                                      Na 138, K 4.5, PLT 380000      CT        Yes   Corticosteroids
  Ries, Guiney et al. [@bib21]   61    M     B/L TKA     9              Warfarin                  Death     Abdominal pain, nausea, fever, hypotension                                     Unknown                        None      Unk   None
  Park et al.\*                  65    F     TKA         8              Enoxaparin                DC home   Abdominal pain, nausea, fever, hypotension                                     Na 126, K 2.6, Hct 25.3        CT        No    Corticosteroids

\*Our patient described in the case report.

###### 

Clinical signs and symptoms of the patients from reported BAH cases.

  Symptoms                              Number of patients
  ------------------------------------- --------------------
  Nausea                                8/16 (50%)
  Abdominal pain                        16/16 (100%)
  Emesis                                3/16 (19%)
  Febrile                               12/16 (75%)
  Confusion/neuropsychiatric symptoms   5/16 (31%)
  Hypotension/Shock                     9/16 (56%)
  Shortness of breath                   2/16 (13%)
